These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease. Savery F Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244 [TBL] [Abstract][Full Text] [Related]
9. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626 [TBL] [Abstract][Full Text] [Related]
10. [Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records]. Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewics E; Wolczyk-Orzechowska M Neurol Neurochir Pol; 1975; 9(5):611-5. PubMed ID: 1186952 [TBL] [Abstract][Full Text] [Related]
11. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial. Ondo WG; Shinawi L; Moore S Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074 [TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism. Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850 [TBL] [Abstract][Full Text] [Related]
13. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease. Lieberman A; Goodgold A; Jonas S; Leibowitz M Neurology; 1975 Oct; 25(10):911-6. PubMed ID: 1101099 [TBL] [Abstract][Full Text] [Related]
14. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Aarli JA; Gilhus NE Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767 [TBL] [Abstract][Full Text] [Related]
15. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial. Gilligan B; Wodak J; Stark R; O'Halloran M Med J Aust; 1979 Aug; 2(4):205-7. PubMed ID: 390336 [TBL] [Abstract][Full Text] [Related]
16. An open trial of controlled release carbidopa/L-dopa (sinemet CR) for the treatment of mild-to-moderate Parkinson's disease. Friedman JH; Lannon MC Clin Neuropharmacol; 1989 Jun; 12(3):220-3. PubMed ID: 2743346 [TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial. Pakkenberg H; Birket-Smith E; Dupont E; Hansen E; Mikkelsen B; Presthus J; Rautakorpi I; Riman E; Rinne UK Acta Neurol Scand; 1976 May; 53(5):376-85. PubMed ID: 1266576 [TBL] [Abstract][Full Text] [Related]
18. Levodopa and the progression of Parkinson's disease. Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Block G; Liss C; Reines S; Irr J; Nibbelink D Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028 [TBL] [Abstract][Full Text] [Related]